EA201990509A1 - Применения ингибитора лизилоксидазаподобного белка 2 - Google Patents

Применения ингибитора лизилоксидазаподобного белка 2

Info

Publication number
EA201990509A1
EA201990509A1 EA201990509A EA201990509A EA201990509A1 EA 201990509 A1 EA201990509 A1 EA 201990509A1 EA 201990509 A EA201990509 A EA 201990509A EA 201990509 A EA201990509 A EA 201990509A EA 201990509 A1 EA201990509 A1 EA 201990509A1
Authority
EA
Eurasian Patent Office
Prior art keywords
inhibitor
lysyloxidase
similar protein
loxl2
protein
Prior art date
Application number
EA201990509A
Other languages
English (en)
Inventor
Гретхен Бэйн
Джиллиан Фрэнсис Эванс
Дейдре А. Маккенна
Джон Говард Хатчинсон
Original Assignee
Фармакеа, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Фармакеа, Инк. filed Critical Фармакеа, Инк.
Priority claimed from PCT/US2017/050331 external-priority patent/WO2018048942A1/en
Publication of EA201990509A1 publication Critical patent/EA201990509A1/ru

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

В настоящем документе описано применение ингибитора LOXL2 при лечении или предупреждении развития состояний, заболеваний или нарушений, связанных с активностью LOXL2.
EA201990509A 2017-05-22 2017-09-06 Применения ингибитора лизилоксидазаподобного белка 2 EA201990509A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762509460P 2017-05-22 2017-05-22
PCT/US2017/050331 WO2018048942A1 (en) 2016-09-07 2017-09-06 Uses of a lysyl oxidase-like 2 inhibitor

Publications (1)

Publication Number Publication Date
EA201990509A1 true EA201990509A1 (ru) 2019-09-30

Family

ID=68000166

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201990509A EA201990509A1 (ru) 2017-05-22 2017-09-06 Применения ингибитора лизилоксидазаподобного белка 2

Country Status (1)

Country Link
EA (1) EA201990509A1 (ru)

Similar Documents

Publication Publication Date Title
PH12019501575A1 (en) ISOFORM-SPECIFIC, CONTEXT-PERMISSIVE TGFá1 INHIBITORS AND USE THEREOF
CL2018002698A1 (es) Tratamiento de enfermedades inflamatorias con inhibidores de actividad c5a
CY1124407T1 (el) Ενωσεις αναστολεα αυτοταξινης
PH12017501611A1 (en) Fluorinated lysyl oxidase-like 2 inhibitors and uses thereof
BR112019006160A2 (pt) composições e métodos para o tratamento das condições oftálmicas
MX2019002612A (es) Usos de un inhibidor de lisil-oxidasa tipo 2.
GEP20247593B (en) Compositions and methods of inhibiting masp-3 for the treatment of various diseases and disorders
CL2018002814A1 (es) Composiciones y metodos para el tratamiento de heridas, trastornos, y enfermedades de la piel.
CL2020000173S1 (es) Masajeador.
BR112016022855A2 (pt) composições e métodos para modular a expressão de pkk
PH12020551683A1 (en) Biomarkers for graft-versus-host disease
EA201792604A1 (ru) Ингибиторы аутотаксина и их применения
TWD173737S (zh) 肌肉鍛鍊機器
BR112018001853A2 (pt) métodos para tratamento de um distúrbio e para melhoria do tratamento de um distúrbio
SG10201808940WA (en) Nox inhibitor and nfкb inhibitor containing methoxyflavone
MX2017004473A (es) Formulaciones de betalactamasa y usos de las mismas.
MD3347002T2 (ro) Tratamentul bolii Alzheimer într-o populație specifică de pacienți
MX2021010886A (es) Uso de medicamentos para disminuir la evolucion de la enfermedad de parkinson.
MX2019002960A (es) Oligonucleótidos modificados y métodos de uso.
EA201792610A1 (ru) Способ лечения неврологического заболевания
EP3702470A3 (en) Reduction of er-mam-localized app-c99 and methods of treating alzheimer's disease
UY38352A (es) Inhibidores de integrina alfavbeta6
EA201990509A1 (ru) Применения ингибитора лизилоксидазаподобного белка 2
RU2016108801A (ru) Пептид, обладающий лечебным действием против болезни Альцгеймера
JP1704674S (ja) 缶